Off-Label Use of Approved Drugs: Therapeutic Opportunity and Challenges

Journal of the American Society of Nephrology : JASN - United States
doi 10.1097/01.asn.0000118323.41076.01
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Off-Label Use of Approved Drugs

Nature Reviews Clinical Oncology
Oncology
2009English

Off-Label Use of Anticancer Drugs in South Korea

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Medical Liability for Off Label Use of Drugs in Romania

Revista de Chimie
SurfacesMaterials ScienceEngineeringMaterials ChemistryFilmsCoatingsChemistry
2018English

Methylphenidate Off-Label Use and Safety

SpringerPlus
Multidisciplinary
2014English

«Off Label Use»: Nouvelles Recommandations

Bulletin des Médecins Suisses
2007English

PND7 Off-Label Use of Antiepileptic Drugs and Its Costs – A Drug Utilization Study in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Reasons for and Frequency of Off - Label Drug Use

Medicinski Pregled
Medicine
2015English

Off-Label Drug Use in Hospitalized Children

Archives of Pediatrics & Adolescent Medicine
2007English

Off-Label Use of Omalizumab in Pediatric Anaphylaxis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy